Bernard Roizman to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Bernard Roizman has written about Xenograft Model Antitumor Assays.
Connection Strength
0.028
-
Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res. 2007 Sep 01; 67(17):8301-6.
Score: 0.015
-
Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. Cancer Res. 2005 Oct 15; 65(20):9479-84.
Score: 0.013